Evidence map›Paper›PMID 35937654›Full record

ArticleCentral European journal of urology2022

Preliminary trial of 24 vs 72 hour perioperative meropenem in patients with ESBL-producing

Marcin Radko, Aneta Guzek, Tomasz Syryło, Zbigniew Rybicki, Henryk Zieliński

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Central European journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Marcin RadkoDepartment of General, Oncological and Functional Urology, Military Institute of Medicine, Warsaw, Poland.
Aneta GuzekDepartment of Laboratory Diagnostics, Section of Microbiology, Military Institute of Medicine, Warsaw, Poland.
Tomasz SyryłoDepartment of General, Oncological and Functional Urology, Military Institute of Medicine, Warsaw, Poland.
Zbigniew RybickiDepartment of Anesthesiology and Intensive Care Therapy, Military Institute of Medicine, Warsaw, Poland.
Henryk ZielińskiDepartment of General, Oncological and Functional Urology, Military Institute of Medicine, Warsaw, Poland.
Wojskowy Instytut Medycyny Lotniczej · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Antimicrobial prophylaxis is an important issue in positive urine culture patients undergoing endourological procedures or extracorporeal shock wave lithotripsy (ESWL). It is especially recognized in asymptomatic bacteriuria patients of alarm pathogen etiology. We designed a preliminary study to determine optimal duration of antibiotic prophylaxis in patients undergoing endourological procedures or ESWL with asymptomatic bacteriuria caused by Material and methods: A total of 60 patients with confirmed ESBL+ Results: Values of white blood count, C-reactive protein and procalcitonin prior to, 24 hours and seven days after the procedure clearly showed no statistically significant differences between groups that have received a one-day and three-day antibiotic regimen. Conclusions: In patients with ESBL+

Indexed as

asymptomatic bacteriuriaextended spectrum beta-lactamaseextracorporeal shock wave lithotripsymeropenemprophylaxisureteroscopy

Identifiers

PMID35937654
PMCPMC9326705
OpenAlexW4285277616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.